ARIBIOLAB Q3 operating loss of KRW 1.7 billion, cumulative revenue of KRW 0.2 billion
AI summary · Not investment advice
Aribio Lab sold KRW 0.2 billion from January to September, and lost KRW 1.7 billion from its main business in Q3, versus a KRW 3.4 billion loss a year earlier.
Operating profit · 3 months
KRW -1.7 billion
Key facts
- Net income (3 months)
- KRW -2.0 billion
- Period
- Q3 (cumulative Jan 1, 2026 ~ Sep 30, 2026)
- Revenue (year to date)
- KRW 173.2 millionNo revenue figure for the current 3 months in the source
- Operating profit (prior-year 3 months)
- KRW -3.4 billion
- Operating profit (year to date)
- KRW -5.8 billion
- Net income (prior-year 3 months)
- KRW -3.8 billion
- Net income (year to date)
- KRW -6.7 billion
Commentary
AI commentary · Not investment advice
What happened
Ariobiolab filed its report for the third quarter of 2026. On a standalone basis, sales for January to September total KRW 173.16 million. Sales for the latest 3 months alone are not given in the filing.
In the company's terms
Operating profit (profit from the core business) was KRW -1.67480 billion for the latest 3 months. The same period a year earlier was KRW -3.42072 billion. The year-to-date figure is KRW -5.83906 billion.
What changes for shareholders
Net income (the final profit after all costs and taxes) was KRW -1.96117 billion for the latest 3 months. The same period a year earlier was KRW -3.75622 billion. The year-to-date figure is KRW -6.69691 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
A